background image

Paid Clinical Trials Laramie

Discover 36 paid clinical trials in Laramie, Wyoming. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Randomized Trial to Evaluate Sequential vs Simultaneous Patching

Recruiting
PHASE3

Sponsor:

Jaeb Center for Health Research

Location:

Laramie WY, Salt Lake City UT, Omaha NE, Boise IDshow 54 more

Code:

NCT04378790

Conditions

Amblyopia

Eligibility Criteria

Sex: All

Age: 3 - 13

Healthy Volunteers: Not accepted

Interventions

Patching

Glasses

MFOLFIRINOX Versus MFOLFOX with or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Recruiting
PHASE3

Sponsor:

Alliance for Clinical Trials in Oncology

Location:

Cheyenne WY, Fort Collins CO, Loveland CO, Greeley COshow 465 more

Code:

NCT05677490

Conditions

Advanced Esophageal Adenocarcinoma

Advanced Gastric Adenocarcinoma

Advanced Gastroesophageal Junction Adenocarcinoma

Clinical Stage III Esophageal Adenocarcinoma AJCC V8

Clinical Stage III Gastric Cancer AJCC V8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Fluorouracil

Leucovorin Calcium

Oxaliplatin

Irinotecan

Nivolumab

MILD® Percutaneous Image-Guided Lumbar Decompression: a Medicare Claims Study

Recruiting

Sponsor:

Vertos Medical, Inc.

Location:

Fort Collins CO, Rawlins WY, Broomfield CO, Golden COshow 1071 more

Code:

NCT03072927

Conditions

Lumbar Spinal Stenosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MILD

Interspinous Process Decompression

Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer

Recruiting
PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Cheyenne WY, Loveland CO, Greeley CO, Boulder COshow 257 more

Code:

NCT04164082

Conditions

Bladder Flat Urothelial Carcinoma In Situ

Non-Muscle Invasive Bladder Urothelial Carcinoma

Stage 0a Bladder Cancer AJCC v8

Stage 0is Bladder Cancer AJCC v8

Stage I Bladder Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biopsy

Biospecimen Collection

Computed Tomography

Cystoscopy

Gemcitabine Hydrochloride

S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration

Recruiting
PHASE3

Sponsor:

SWOG Cancer Research Network

Location:

Cheyenne WY, Longmont CO, Boulder CO, Lafayette COshow 530 more

Code:

NCT04071457

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Lenalidomide

Daratumumab/rHuPH20

T-DM1 and Tucatinib Compared with T-DM1 Alone in Preventing Relapses in People with High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial

Recruiting
PHASE3

Sponsor:

Alliance for Clinical Trials in Oncology

Location:

Cheyenne WY, Fort Collins CO, Loveland CO, Greeley COshow 756 more

Code:

NCT04457596

Conditions

Anatomic Stage IA Breast Cancer AJCC V8

Anatomic Stage II Breast Cancer AJCC V8

Anatomic Stage IIA Breast Cancer AJCC V8

Anatomic Stage IIB Breast Cancer AJCC V8

Anatomic Stage III Breast Cancer AJCC V8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Trastuzumab Emtansine

Placebo Administration

Tucatinib

Questionnaire Administration

Quality-of-Life Assessment

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Recruiting
PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Cheyenne WY, Loveland CO, Greeley CO, Longmont COshow 415 more

Code:

NCT04181060

Conditions

Advanced Lung Non-Squamous Non-Small Cell Carcinoma

Metastatic Lung Non-Squamous Non-Small Cell Carcinoma

Recurrent Lung Non-Squamous Non-Small Cell Carcinoma

Stage IIIB Lung Cancer AJCC v8

Stage IV Lung Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bevacizumab

Biospecimen Collection

Computed Tomography

Echocardiography

Magnetic Resonance Imaging

Sustaining Physical Activity After Cancer Exercise Sessions

Recruiting

Sponsor:

Colorado State University

Location:

Laramie WY, Fort Collins CO, Aurora CO

Code:

NCT06359210

Conditions

Exercise Oncology

Physical Activity Behavior

Behavior Change Interventions

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Responder Monthly Behavior Change Discussion Sessions

Incomplete Responder Monthly Behavior Change Discussion Sessions

Incomplete Responder Monthly Behavior Change Discussion Sessions + Bi-Weekly Exercise Sessions

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Recruiting
PHASE3

Sponsor:

ECOG-ACRIN Cancer Research Group

Location:

Cheyenne WY, Loveland CO, Greeley CO, Longmont COshow 463 more

Code:

NCT03937635

Conditions

Smoldering Plasma Cell Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Daratumumab

Dexamethasone

Lenalidomide

Quality-of-Life Assessment

Questionnaire Administration

Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.

Recruiting
PHASE3

Sponsor:

Amneal Pharmaceuticals, LLC

Location:

Cheyenne WY, Newport Beach CA, Austin TX, Petaluma CAshow 5 more

Code:

NCT05401357

Conditions

Glaucoma, Open-Angle

Ocular Hypertension

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Test - Bimatoprost 0.01% Ophthalmic Solution

Reference - LUMIGAN® (Bimatoprost 0.01% Ophthalmic Solution)